Literature DB >> 1825050

Femoropopliteal angioplasty. Factors influencing long-term success.

P Capek1, G K McLean, H D Berkowitz.   

Abstract

Prospective data was recorded on 217 percutaneous transluminal angioplasty (PTA) procedures performed in the superficial femoral and popliteal arteries over an 8-year period. After the initial procedure, patients were followed with serial noninvasive studies and, in 71 patients, repeat angiography. The mean follow-up period was 7 years (range, 2-11 years). Standard life-table survival analysis was used to assess the factors potentially affecting long-term outcome. Excluding an initial technical failure rate of 10%, overall patencies at 1, 3, and 5 years were 81%, 61%, and 58%, respectively. After the first year, the prognosis (i.e., failure rate) appears to be linear over the long term (i.e., up to 10 years). Factors negatively influencing long-term patency include the presence of diabetes mellitus, diffuse atherosclerotic cardiovascular disease, or threatened limb loss. Technical factors correlated with failure include lesion length, moderate eccentricity, and a poor post-PTA appearance.

Entities:  

Mesh:

Year:  1991        PMID: 1825050

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  38 in total

Review 1.  Cutting balloons for the treatment of vascular stenoses.

Authors:  Dimitrios Tsetis; Robert Morgan; Anna-Maria Belli
Journal:  Eur Radiol       Date:  2006-04-12       Impact factor: 5.315

2.  Femoropopliteal artery recanalization: factors affecting clinical outcome of conventional and laser-assisted balloon angioplasty.

Authors:  H F Odink; H C de Valois; B C Eikelboom
Journal:  Cardiovasc Intervent Radiol       Date:  1995 May-Jun       Impact factor: 2.740

3.  Improved detection of in-stent restenosis by blood pool agent-enhanced, high-resolution, steady-state magnetic resonance angiography.

Authors:  Christina M Plank; Florian Wolf; Herbert Langenberger; Michael Weber; Dietrich Beitzke; Alfred Stadler; Martin Schillinger; Johannes Lammer; Christian Loewe
Journal:  Eur Radiol       Date:  2011-05-10       Impact factor: 5.315

4.  Re-entry devices in the treatment of peripheral chronic occlusions.

Authors:  Marcus Smith; Reji Pappy; Thomas A Hennebry
Journal:  Tex Heart Inst J       Date:  2011

Review 5.  Drug-coated balloon and stent therapies for endovascular treatment of atherosclerotic superficial femoral artery disease.

Authors:  Subhash Banerjee; Karan Sarode; Atif Mohammad; Emmanouil S Brilakis
Journal:  Curr Cardiol Rep       Date:  2015-05       Impact factor: 2.931

Review 6.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

Review 7.  Peripheral artery disease. Part 2: medical and endovascular treatment.

Authors:  Mitchell D Weinberg; Joe F Lau; Kenneth Rosenfield; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-06-14       Impact factor: 32.419

Review 8.  An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.

Authors:  Nicolas W Shammas
Journal:  Int J Angiol       Date:  2013-03

Review 9.  Evidence-based management of peripheral vascular disease.

Authors:  Nicolas W Shammas; Eric J Dippel
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

10.  Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review.

Authors:  Christos Kasapis; Hitinder S Gurm
Journal:  Curr Cardiol Rev       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.